Abstract: Somatic stem cells possess unique properties of self-renewal and plasticity which make them promising candidates for use in tissue engineering and regenerative medicine, in addition to serving as efficient delivery vehicles in site-specific therapy. In the case of therapeutic application, it is essential to isolate and culture stem cells in vitro, to obtain them in sufficient quantities. Although long-term cultivation provides an adequate number of cells, it has been shown that this approach is associated with increased risk of transformation of cultured cells, which presents a significant biological hazard. This article reviews information about biological features and cellular events which occur during long-term cultivation of somatic stem cells, with respect to their safe utilization in potential clinical practice.
INTRODUCTION
Somatic stem cells represent a heterogeneous adult cellular population, defined by special characteristics such as self-renewal and broad differentiation potential [1] . Over the past few years, somatic stem cells have been derived from various tissues, including bone marrow, adipose tissue, muscles, umbilical cord, dental pulp, etc. [2] [3] [4] [5] [6] [7] [8] . They have a potential to adhere to plastic, and under in vitro conditions they have a fibroblast-like morphology as well as being able to produce colony colony-forming unit-fibroblasts (CFU-F). These cells express a variety of surface markers including CD29, CD44, CD56, CD73, CD90, CD105, CD106, CD133, CD166, CD271, STRO-1 and Sca-1; but they are negative for hematopoietic and blood lineage markers, including CD14, CD31, CD34, CD45 and c-Kit. Moreover, the majority of them do not express HLA class II [1] . In the organism they play pivotal roles during embryogenesis, regeneration and reparation. Moreover, they possess high immunosuppressive capacity, as well as the capacity to migrate to sites of injury, inflammation or tumor areas. These characteristics make stem cells promising candidates for use in tissue engineering and regenerative medicine. On the other hand, all these unique properties of stem cells are similar to tumor cells, making normal stem cells ideal candidates to undergo transformation. Recently, somatic stem cells have been used as a basic component of novel stem cell-based therapies and therapeutic strategies in different medical areas such as orthopedics, urology, dental surgery, cardiology and endocrinology. Somatic stem cells can be easily isolated in different yields with varying effectiveness. Nevertheless, the growth rate of stem cells seems to be origindependent [9] and clonal variability exists among the stem cell clones derived from the same tissue source of different donors [10] . In the case of therapeutic application, it is crucial to isolate and expand stem cells in vitro to obtain a sufficient quantity. Although long-term cultivation provides an adequate number of cells, it has been shown that this approach is associated with increased risk of transformation of cultured cells, which presents a significant biological hazard. Therefore, the standard cultivation protocols, which maintain stem cell characteristics while avoiding or delaying senescence and genetic instability, are essential prerequisites for assuring their durable engraftment and long-term therapeutic effect [11] . The main goal of the present article is to provide an overview of cellular events during long-term cultivation of somatic stem cells, with respect to their safe utilization in potential clinical practice.
STEM CELL AGING
Normal human aging is a complex biological process that results from gradual phenotypic and functional changes of cells in time (Fig. 1) . The age-associated pathophysiological changes typically lead to an imbalance that favors mechanisms of replicative senescence and programmed cell death (apoptosis) [12] . Mammalian aging is associated with reduced tissue regeneration, increased degenerative diseases and cancer [13] . Most tissue-resident adult stem/progenitor cells have a long lifespan. However, factors such as cumulative loss of telomeric DNA, defects in DNA repair mechanisms, oxidative stress or ultraviolet radiation-induced DNA damage and chromosomal instability during the aging of adult stem cells may trigger different cell cycle checkpoint mechanisms initiated through different signaling elements [12] . These mechanisms comprise an upregulation of tumor suppressor gene products including p16, p19, p53, pRb. The activation of these signaling pathways may result in inhibition of activities of cyclin-dependent kinase/cyclin complexes and repression of transcription factors and thereby lead to cell growth inhibition or senescence and apoptosis [14] . In contrast to apoptotic cells, senescent cells accumulate in tissue. These cells are then susceptible to malignant transformation. Conversely, ectopic expression of the telomerase catalytic subunit may lead to activation of telomerase, maintaining the telomere length and thus extension of lifespan of adult stem/progenitor cells and their progenies. Telomerase re-activation and inactivation of the tumor suppressor gene product in adult stem cells, during chronological aging, may lead to a bypass of the senescence or apoptotic cell death programs, and thereby promote cancer initiation [15] . Also changes in the niche -the stem cell's microenvironment -may occur with chronological aging, inflammation or oxidative stress and have detrimental consequences for tissue regeneration and homeostatic conditions. That can cause development of various diseases [16] . Cancer is closely related to aging in that the incidence of cancer increases exponentially with age [17] . Stem cells have an essential role in tissue homeostasis. However, during aging, many tissues show a decline in regenerative potential associated with loss of stem cell numbers and function. For that reason, it is important to clarify the age-associated factors and regulatory mechanisms associated with the stem cell aging process. Yu and Kang [18] reviewed and discussed recent data related to age-associated genes in mesenchymal stem cells (MSCs), focused on epigenetic regulatory factors, transcription factors and cell signaling. They mentioned, in particular, activities of epigenetic regulatory factors, including histone acetylase and DNA methyltransferase, which modulate gene expression and crosstalk with each other during the MSC senescence process. The most studied epigenetic process, with respect to spontaneous malignant transformation, is DNA methylation of senescence-related genes which leads to their altered expression. The decreased expression of these genes, alone or in combination with downexpression of other genes (e.g. p21, p27), affects the regulation of cyclindependent kinases and alters the function of the G1/S cell cycle checkpoint [19] . The second important epigenetic process is histone modification. It has been shown that acetylation alteration patterns were changed in long-term cultures of fetal placental stem cells accompanied by increased global histone deacetylase (HDAC) activity and expression of several HDAC subtypes [20] .
MOLECULAR MECHANISMS INVOLVED IN AGING AND MALIGNANT TRANSFORMATION OF SOMATIC STEM/PROGENITOR CELLS
Gate-keeping tumor suppressors (such as p16 INK4A , p19
Arf and p53) negatively regulate cellular proliferation and survival [21] . These gene products are probably evolved to regulate homeostasis in normal tissues, by regulating the proliferation and survival of normal cells. Their role in cancer is reflected by the ability of cancer cells to evade normal homeostatic controls through deleting these genes. Gate-keeping tumor suppressors tend to negatively regulate stem cell function [22] and aging due to their expression and/or function increase with age [23] [24] [25] [26] . The increase in gate-keeping tumor suppressor expression in aging tissues and the onset of senescence in some aging cells may explain the increased incidence of cancer during aging [27, 26] . Tumor suppressor protein (also cyclin-dependent kinase inhibitor) p16
INK4A is involved in growth arrest, cellular senescence and apoptosis. Expression of p16 INK4A gradually increases, for example, in aging mouse and human tissues [23, 29] , reducing stem cell incidence and self-renewal potential in multiple tissues. In MSCs, p16
INK4A
-positive cells show growth retardation and increased activity of senescence-associated β-galactosidase. Up-regulation of p16 INK4A causes reduced self-renewal in stem cells. The p53 tumor suppressor is a sequence-specific transcription factor and acts as a central hub, sensing various stress signals and activating an array of target genes to induce cell cycle arrest, DNA repair, apoptosis and cellular senescence [30] . The p53-mediated cellular senescence leads to aging-related phenotypes, such as tissue atrophy, stem cell depletion, and impaired wound healing [31] .
If the TP53 gene is damaged, tumor suppression is severely reduced. People who inherit only one functional copy of the TP53 gene will most likely develop tumors in early adulthood, a disorder known as Li-Fraumeni syndrome. The TP53 gene can also be damaged in cells by mutagens (chemicals, radiation or viruses) and then cause genetic instability and phenotype plasticity, which further leads to random mutations and formation of clones. More than 50 percent of human tumors contain mutation or deletion of the TP53 gene [32] . On the other hand, elevated p53 expression or constitutive p53 activation can also cause depletion of stem cells [33] , encourage premature aging, and shorten life span, despite reducing cancer incidence [34] [35] [36] . This suggests that increased p53 activity protects against cancer, but at the same time may promote aging and shorten life span, if a certain threshold activity is reached. Cancer suppression may not be the only function of gate-keeping tumor suppressors in aging stem/progenitor cells. They might also help sustain tissue homeostasis by suppressing pathological or dysplastic proliferation or aberrant differentiation in aging tissues.
STEM CELL NICHE AND A-TYPE LAMINS
Pekovic and Hutchison [37] focus on the stem cell niche, which can modulate how stem cells participate in tissue regeneration, maintenance and repair [38] . Stem cell niches are diverse and comprise a variety of cells, extracellular matrices, and paracrine and endocrine hormonal signals, which all interact with each other. The stem cell niche can have a dual role in stem cell regulation. It may act as a protective barrier against damaging stimuli that lead to stem cell depletion or extensive proliferation, but it can also negatively modify external stimuli and alter the function of stem cells, leading to disease pathologies. Pekovic and Hutchison set forth a hypothesis in which A-type lamins act as intrinsic modulators of aging in adult stem cells and their niches and thus of lifespan. The concept states that nuclear filament proteins, A-type lamins, may act as signaling receptors in the nucleus, required for receiving and/or transducing upstream cytosolic signals in a number of pathways. These are important for adult stem cell maintenance, as well as the adaptive response to stress. They propose that aging, diseases caused by lamin A mutation and dysfunction of the A-type lamin stress-resistant signaling network in adult stem cells, their progenitors and/or stem cell niches lead to loss of protection against growth-related stress [37] . The lamin A gene has been linked to longevity and was proposed to be a guardian of somatic cells during their lifetime [39] . Mutation in the lamin A gene causes a spectrum of 20 age-related disorders termed laminopathies, affecting the maintenance of one or more tissues of mesenchymal origin (skeletal muscle, tendons, adipose tissue, skin, bone, peripheral neurons, myocardium and vasculature). This mutation triggers inappropriate activation or a complete failure of self-renewal pathways with consequent initiation of stress-induced senescence [37] .
SENESCENCE AND STEM CELL NICHE
Cellular senescence is an irreversible cell cycle arrest in response to different pathways (Table 1) . It primarily occurs due to stress signals, telomere dysfunction, oncogene activation, the p53 and p16/Rb signaling pathway, DNA damage and chromosome rearrangements [30, 40] . In 1961, Hayflick and Moorhead observed that normal human diploid cells can have a limited number of passages in vitro, after they enter a metabolically active but non-proliferative phase known as "replicative senescence" or "Hayflick's limit" [41, 42] . Senescent cells are characterized by enlarged cell size, flattened morphology, circumscribed nuclei, increased lysosome compartment, inability to synthesize DNA, and expression of β-galactosidase [43, 44] . Senescent cells accumulate at many tissue sites associated with age-related pathologies, such as atherosclerotic lesions, skin ulcers, arthritic joints, etc. [45] . Senescent cells have significantly up-regulated tumor suppressor genes [10] . Proliferation arrest influences the stem cell karyotype. At least 30% of senescent MSCs display trisomy of chromosome 8. MSCs start to be polyploid (mainly tetraploid) at passage 20, and become aneuploid afterwards [46] . With respect to therapy application, special attention should be paid during culture to MSC epigenetic changes and appearance of senescence, which could result in genomic abnormality [10] . Stem cells have the capacity to escape replicative senescence, which is a common characteristic in all kinds of diploid cell cultures. According to previously published studies, after 4 to 5 months of in vitro culture, 50% of postsenescent stem cell clones can escape the proliferation crisis, lose contact inhibition and become tumor-like transformed stem cells [47] . Transformed stem cells have different morphology; they have a higher nucleus to cytoplasm ratio, prominent nucleoli and more desmosomes [48] . They also possess a high level of telomerase activity and soon become aneuploid with various intrachromosomal translocations [49, 50] . Senescent cells also affect stem cells and their niche. Stem cells are prime targets of carcinogenesis, and the ability of stem cells to undergo senescence is considered an important tumor-suppressive mechanism, which prevents the accumulation of oncogenic mutations in the self-renewing compartments [51] . Accumulation of senescent cells in tissues over time can also change the surrounding stem cell niche by secreting degenerative enzymes, inflammatory cytokines and growth factors that enhance senescence and tumorigenesis [52, 53] and thus compromise tissue repair and renewal [18, 54] . Senescent cells can foster a microenvironment that promotes age-associated diseases and/or neoplastic transformation in old organisms [55] . The molecular pathway of senescence is very complicated, but it is well known that p53 is a pivotal mediator of cellular senescence. Although loss of p53 alone is sufficient for mouse cells to bypass senescence, in the case of human cells, additional inhibition of p16 is required [56] . This suggests that senescence can occur also through a p53-independent mechanism.
TELOMERES AND TELOMERASE
Telomeres are specialized nucleoprotein caps that contain thousands of guaninerich repeated sequences (TTAGGG) located at the ends of chromosomes. They protect the ends of chromosomes from end-to-end fusions that induce DNA damage responses [57, 58] and act as a biological clock limiting the cell proliferation potential with each successive cell division [41] .
Telomerase is a multisubunit ribonucleoprotein that belongs to the reverse transcriptase family [59] . Telomerase is inactive in most somatic cells but active in germ cells, stem cells, actively dividing cells [60] , cancer cells and other immortalized cells [61] . The studies across many tumor types have shown that the vast majority of tumors (85%) express telomerase and hence are able to maintain a stable and homogeneous telomere length so they can avoid replicative senescence [62, 63] . Stem cells taken from young donors can divide 50 to 100 times in in vitro conditions; proliferative activity in older donors is reduced. The telomere shortening rate is 50 bp per population doubling [9, 64] . This gradual shortening of telomeres and lack of telomerase activity results in proliferation arrestreplicative senescence in long-term culture [65, 66] .
MALIGNANT TRANSFORMATION OF LONG-TERM CULTURED STEM CELLS
Evidence . Transformed mesenchymal cells (TMCs) showed a significantly increased proliferation rate with altered morphology and phenotype. TMCs grew well in soft agar assays and were unable to undergo complete differentiation. TMCs were also highly tumorigenic, causing multiple fast-growing lung deposits when injected into immunodeficient mice [50] . Wu and colleagues described the spontaneous malignant transformation of long-term cultured human fetal striatum neural stem cells (hsNSCs, passage 17). After subcutaneous transplantation of long-term cultured hsNSCs into immunodeficient nude mice, 2 out of 15 mice formed xenografts, which expressed neuroendocrine tumor markers [70] . Fig. 2 provides an overview of the most common conditions occurring in prolonged cultivation of stem cells.
Taking the above into consideration, all cultured stem cells have to be checked for biological markers of senescence and malignant transformation (Table 2) prior to their clinical application. 
CONCLUSION
A growing body of experimental evidence has revealed that an increased incidence of certain cancer types including myeloblastic leukemia, glial brain tumors and epithelial cancers may occur with advancing age in humans. More specifically, enhanced inflammation and oxidative stress, telomere shortening or accumulation of particular oncogenic events in adult stem cells during chronological aging may lead to genomic instability that can promote their transformation into precancerous stem cells. This early state of genomic instability can form pre-malignant lesions, followed by an increase of telomerase activity (immortalization) and inactivation of tumor suppressor gene products (p16, pRb, p53), and bypass replicative senescence or the apoptotic death process. Hence, the subsequent accumulation of numerous oncogenic events, such as the activation of distinct growth factor signaling pathways in precancerous stem cells, may culminate in their malignant transformation into highly leukemic or tumorigenic cancer stem cells, cancer initiation and progression during chronological aging. Cancer-initiating cells often exist in a quiescent state; they have active DNA repair, intracellular detoxifying enzymes and anti-apoptotic signaling factors, such as Bcl-2 and survivin, that make them resistant to anti-hormonal therapy, radiotherapy and chemotherapy. These mechanisms demonstrate that the initiation, proliferation and metastasis of cancer are associated with the deregulation of stem cells.
Spontaneous malignant transformation of long-term cultivated cells may represent a significant biological risk in clinical applications -transplantations, regenerative medicine, and cell-based therapies. Therefore further studies are necessary to focus mainly on searching for optimal culture conditions for stem cell expansion, as well as thorough output analysis prior to their utilization in clinical practice.
